Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
Globe Newswire•23/07/2026•08:30 ET
0
Whiz Insights
Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation
510(k) package submission on track for calendar H2 2026, targeting planned entry into multi-billion-dollar U.S. drug screening market
Get started
Create a free account to read the full story.